Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

References for PMC Articles for PubMed (Select 21505207)

1.

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Egan BM, Zhao Y, Axon RN.

JAMA. 2010 May 26;303(20):2043-50. doi: 10.1001/jama.2010.650.

PMID:
20501926
2.

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.

Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S, Grobbee DE, Neal B, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Diabetologia. 2010 May;53(5):821-31. doi: 10.1007/s00125-010-1681-4. Epub 2010 Feb 17.

PMID:
20157695
3.
4.

Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy.

Hoerger TJ, Zhang P, Segel JE, Gregg EW, Narayan KM, Hicks KA.

Diabetes Res Clin Pract. 2009 Dec;86(3):225-32. doi: 10.1016/j.diabres.2009.09.017. Epub 2009 Oct 14.

PMID:
19833403
5.

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr, Savage PJ, Levy D, Fox CS.

Circulation. 2009 Apr 7;119(13):1728-35. doi: 10.1161/CIRCULATIONAHA.108.829176. Epub 2009 Mar 23.

7.

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.

Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ.

Diabetes Care. 2009 Apr;32(4):708-13. doi: 10.2337/dc08-1918. Epub 2008 Dec 29.

8.

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17. No abstract available. Erratum in: Diabetes Care. 2009 Apr;32(4):754.

9.

Trends in hypercholesterolemia, treatment and control among United States adults.

Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH.

Int J Cardiol. 2010 Apr 15;140(2):226-35. doi: 10.1016/j.ijcard.2008.11.033. Epub 2008 Dec 10.

PMID:
19081646
10.

Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.

Metcalf PA, Wells S, Scragg RK, Jackson R.

N Z Med J. 2008 Sep 5;121(1281):49-57.

PMID:
18797484
11.

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C.

Lancet. 2008 Jan 12;371(9607):117-25. doi: 10.1016/S0140-6736(08)60104-X.

PMID:
18191683
12.

Mortality trends in men and women with diabetes, 1971 to 2000.

Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC.

Ann Intern Med. 2007 Aug 7;147(3):149-55. Epub 2007 Jun 18.

PMID:
17576993
13.

Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S.

N Engl J Med. 2007 Jun 7;356(23):2388-98.

14.

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Coleman RL, Stevens RJ, Retnakaran R, Holman RR.

Diabetes Care. 2007 May;30(5):1292-3. Epub 2007 Feb 8. No abstract available.

PMID:
17290036
15.

Trends in serum lipids and lipoproteins of adults, 1960-2002.

Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL.

JAMA. 2005 Oct 12;294(14):1773-81.

PMID:
16219880
17.

Trends in cardiovascular complications of diabetes.

Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr, Wilson PW, Savage PJ.

JAMA. 2004 Nov 24;292(20):2495-9.

PMID:
15562129
18.

Prediction of coronary heart disease in middle-aged adults with diabetes.

Folsom AR, Chambless LE, Duncan BB, Gilbert AC, Pankow JS; Atherosclerosis Risk in Communities Study Investigators.

Diabetes Care. 2003 Oct;26(10):2777-84.

PMID:
14514579
19.
20.

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O.

N Engl J Med. 2003 Jan 30;348(5):383-93.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk